Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 6NIH 1INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 67Lymphoma 56Multiple Myeloma 53Breast Neoplasms 52Neoplasm Metastasis 47Lung Neoplasms 47Prostatic Neoplasms 46Leukemia, Myeloid, Acute 40Ovarian Neoplasms 39Melanoma 37Carcinoma, Non-Small-Cell Lung 37Hematologic Neoplasms 36Colorectal Neoplasms 32Pancreatic Neoplasms 29Glioma 28Lymphoma, Non-Hodgkin 26Urinary Bladder Neoplasms 25Sarcoma 25Carcinoma, Renal Cell 25Brain Neoplasms 23Neuroblastoma 21Myelodysplastic Syndromes 21Triple Negative Breast Neoplasms 19Fallopian Tube Neoplasms 19Stomach Neoplasms 18Leukemia, Lymphocytic, Chronic, B-Cell 18Burkitt Lymphoma 18Small Cell Lung Carcinoma 17Colonic Neoplasms 17Glioblastoma 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Metabolic Syndrome × 90 days × Clear all
NCT01143480 2026-06-01

Study of the Effect of Innate on the Inflammatory Response to Endotoxin

National Institutes of Health Clinical Center (CC)

Recruiting
725 enrolled

Asthma, Insulin Resistance, Neoplasms, Metabolic Syndrome, Atherosclerosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡